These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33191406)

  • 1. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors.
    Goss KL; Koppenhafer SL; Waters T; Terry WW; Wen KK; Wu M; Ostergaard J; Gordon PM; Gordon DJ
    Oncogene; 2021 Jan; 40(3):564-577. PubMed ID: 33191406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
    Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
    Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
    He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
    Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.
    Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
    Mol Cancer Ther; 2018 Dec; 17(12):2676-2688. PubMed ID: 30282812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
    Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P
    Cancer Lett; 2024 Aug; 596():216993. PubMed ID: 38801884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response.
    Zhang YW; Jones TL; Martin SE; Caplen NJ; Pommier Y
    J Biol Chem; 2009 Jul; 284(27):18085-95. PubMed ID: 19416980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
    Croushore EE; Koppenhafer SL; Goss KL; Geary EL; Gordon DJ
    Cancer Res Commun; 2023 Aug; 3(8):1580-1593. PubMed ID: 37599787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.
    Foskolou IP; Jorgensen C; Leszczynska KB; Olcina MM; Tarhonskaya H; Haisma B; D'Angiolella V; Myers WK; Domene C; Flashman E; Hammond EM
    Mol Cell; 2017 Apr; 66(2):206-220.e9. PubMed ID: 28416140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
    Müller D; Shin S; Goullet de Rugy T; Samain R; Baer R; Strehaiano M; Masvidal-Sanz L; Guillermet-Guibert J; Jean C; Tsukumo Y; Sonenberg N; Marion F; Guilbaud N; Hoffmann JS; Larsson O; Bousquet C; Pyronnet S; Martineau Y
    JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31672935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
    Haight JA; Koppenhafer SL; Geary EL; Gordon DJ
    Front Oncol; 2024; 14():1394653. PubMed ID: 38933441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition.
    Shu Z; Li Z; Huang H; Chen Y; Fan J; Yu L; Wu Z; Tian L; Qi Q; Peng S; Wei C; Xie Z; Li X; Feng Q; Sheng H; Li G; Wei D; Shan C; Chen G
    Oncogene; 2020 Aug; 39(35):5721-5733. PubMed ID: 32712628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
    Chen G; Luo Y; Warncke K; Sun Y; Yu DS; Fu H; Behera M; Ramalingam SS; Doetsch PW; Duong DM; Lammers M; Curran WJ; Deng X
    Nat Commun; 2019 Jul; 10(1):3213. PubMed ID: 31324785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer.
    Wu L; Yin L; Ma L; Yang J; Yang F; Sun B; Nianzeng X
    Aging (Albany NY); 2022 Oct; 14(19):7890-7905. PubMed ID: 36202136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.
    Yin X; Jiang K; Zhou Z; Yu H; Yan D; He X; Yan S
    Oxid Med Cell Longev; 2023; 2023():3878796. PubMed ID: 36713030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition.
    Okonska A; Bühler S; Rao V; Ronner M; Blijlevens M; van der Meulen-Muileman IH; de Menezes RX; Wipplinger M; Oehl K; Smit EF; Weder W; Stahel RA; Penengo L; van Beusechem VW; Felley-Bosco E
    Mol Cancer Ther; 2020 Feb; 19(2):552-563. PubMed ID: 31619462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development.
    Specks J; Lecona E; Lopez-Contreras AJ; Fernandez-Capetillo O
    Mol Cell Biol; 2015 Sep; 35(17):2910-7. PubMed ID: 26077802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
    Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
    Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
    Haight JA; Koppenhafer SL; Geary EL; Gordon DJ
    bioRxiv; 2024 May; ():. PubMed ID: 38798568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation.
    Kitab B; Satoh M; Ohmori Y; Munakata T; Sudoh M; Kohara M; Tsukiyama-Kohara K
    J Biol Chem; 2019 Apr; 294(15):5759-5773. PubMed ID: 30755480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
    Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.